I woluld suggest the largest exaggeration (I am being polite saying exaggeration) was the 600kg of product available right now, Masila estimated that would be around $40mil in inventory, which is likely high given he/she was using the fair market value not the cost, but say inventory would be $20-30 mill for the 600kg. 

The last financials show only $5mill of clinical supplies short and long term (if inventory, typically the statements explicity say inventory not supplies). But even if I say the clinical supplies is maded up of mostly inventory, that means RVX has spent $15- 25mill on stockpiling inventory. We all know that is impossible given the funding they have received since Jan 1, especially given the Hepa raise was recent and is likely going to pay payables and fund the COVID trial (if that ever starts) The only thing we should take as fact is medical research papers and actual trials and nothing else that is said.